title: Trial watch: HIV integrase inhibitor-based regimen beats market leader.
authors.forename: Sarah
authors.initials: S
authors.lastname: Crunkhorn
mesh_terms: D017326:Clinical Trials, Phase III as Topic / Q000639:trends; D015658:HIV Infections / Q000188:drug therapy / Q000201:enzymology* / Q000453:epidemiology; D019427:HIV Integrase / Q000378:metabolism*; D019428:HIV Integrase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans
chemical_list: D019428:HIV Integrase Inhibitors; D019427:HIV Integrase